Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study.
暂无分享,去创建一个
J. Mate | A. Ariza | D. Lopez | M. Isamat | E. Musulen | M. Pujol | A. Ley | J. Navas-Palacios | D. López | J. Navas‐Palacios | J. Maté | Aurelio Ariza | Marc Isamat | Eva Musulen | Magda Pujol | Adolfo Ley | Eva Musulen
[1] G. Pilkington. Tumour Cell Migration in the Central Nervous System , 1994, Brain pathology.
[2] X. Yang,et al. Expression of CD44 in human lung tumors. , 1994, Cancer research.
[3] Erwin G. Van Meir,et al. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. , 1993, Cancer research.
[4] G. Screaton,et al. CD44 and cancer screening , 1993, The Lancet.
[5] P. Herrlich,et al. Splicing choice from ten variant exons establishes CD44 variability. , 1993, Nucleic acids research.
[6] P. Herrlich,et al. Prevention of tumor metastasis formation by anti-variant CD44 , 1993, The Journal of experimental medicine.
[7] G. Screaton,et al. CD44 and cancer , 1993, The Lancet.
[8] A. Bignami,et al. Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. , 1992, Experimental cell research.
[9] D. Tarin,et al. Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.
[10] Erwin G. Van Meir,et al. Differential expression of the CD44 molecule in human brain tumours , 1992, International journal of cancer.
[11] L. Becker,et al. Localization of the CD44 Glycoprotein to Fibrous Astrocytes in Normal White Matter and to Reactive Astrocytes in Active Lesions in Multiple Sclerosis , 1991, Journal of neuropathology and experimental neurology.
[12] Martin Hofmann,et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.
[13] M. Amiot,et al. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.
[14] K. Miyake,et al. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition , 1990, The Journal of experimental medicine.
[15] I. Stamenkovic,et al. CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.
[16] R. Schulte,et al. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. , 1990, Experimental cell research.
[17] L. Picker,et al. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types , 1989, The Journal of cell biology.
[18] R. Stern,et al. The extracellular matrix of the central and peripheral nervous systems: structure and function. , 1988, Journal of neurosurgery.
[19] William,et al. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. , 1988, The Journal of biological chemistry.
[20] A. Steere,et al. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. , 1986, Science.
[21] E. Butcher,et al. Homing Receptors and the Control of Lymphocyte Migration , 1986, Immunological reviews.
[22] C. Isacke,et al. Structural heterogeneity of human Pgp-1 and its relationship with p85 , 2004, Immunogenetics.